1. Home
  2. CHGG vs ACET Comparison

CHGG vs ACET Comparison

Compare CHGG & ACET Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Chegg Inc.

CHGG

Chegg Inc.

HOLD

Current Price

$0.89

Market Cap

103.4M

Sector

Real Estate

ML Signal

HOLD

Logo Adicet Bio Inc.

ACET

Adicet Bio Inc.

HOLD

Current Price

$0.62

Market Cap

111.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CHGG
ACET
Founded
2005
1947
Country
United States
United States
Employees
N/A
N/A
Industry
Other Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
103.4M
111.9M
IPO Year
2013
N/A

Fundamental Metrics

Financial Performance
Metric
CHGG
ACET
Price
$0.89
$0.62
Analyst Decision
Sell
Buy
Analyst Count
5
4
Target Price
$1.42
$8.50
AVG Volume (30 Days)
3.0M
1.8M
Earning Date
11-10-2025
11-05-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$447,733,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.44
$0.45
52 Week High
$2.73
$1.19

Technical Indicators

Market Signals
Indicator
CHGG
ACET
Relative Strength Index (RSI) 39.00 41.57
Support Level $0.87 $0.58
Resistance Level $1.01 $0.70
Average True Range (ATR) 0.11 0.06
MACD 0.00 0.01
Stochastic Oscillator 4.93 41.88

Price Performance

Historical Comparison
CHGG
ACET

About CHGG Chegg Inc.

Chegg Inc is an American educational services company. The Chegg platform provides products and services to support learners with their academic course materials, as well as their career and personal skills development. The company's service and product offerings fall into two categories: Subscription Services, which encompasses Chegg Study Pack, Chegg Study, Chegg Writing, Chegg Math, and Busuu offerings that can be accessed internationally through the company's websites and on mobile devices, and Skills and Other, which encompasses skills, advertising services, print textbooks, and eTextbooks offerings.

About ACET Adicet Bio Inc.

Adicet Bio Inc is a clinical-stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer and other diseases. Its product candidate, ADI-001, a first-in-class allogeneic gamma delta T cell therapy expressing a CAR targeting CD20, is being developed for the potential treatment of autoimmune diseases and relapsed or refractory aggressive B cell non-Hodgkin's lymphoma. Their pipeline also includes its preclinical candidate, ADI-270, an armored gamma delta CAR T cell product candidate targeting renal cell carcinoma, with potential for other CD70+ solid tumor and hematological malignancies indications.

Share on Social Networks: